232 related articles for article (PubMed ID: 32655635)
1. Relationship between Prolactin, Chronic Kidney Disease, and Cardiovascular Risk.
Dourado M; Cavalcanti F; Vilar L; Cantilino A
Int J Endocrinol; 2020; 2020():9524839. PubMed ID: 32655635
[TBL] [Abstract][Full Text] [Related]
2. Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation.
Wojtaszek E; Oldakowska-Jedynak U; Kwiatkowska M; Glogowski T; Malyszko J
Oxid Med Cell Longev; 2021; 2021():6651367. PubMed ID: 33628373
[TBL] [Abstract][Full Text] [Related]
3. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease.
Kendrick J; Chonchol MB
Nat Clin Pract Nephrol; 2008 Dec; 4(12):672-81. PubMed ID: 18825155
[TBL] [Abstract][Full Text] [Related]
4. Heart and kidney disease: a cardiovascular high-risk constellation.
Schunk SJ; Speer T; Fliser D
Herz; 2021 Jun; 46(3):206-211. PubMed ID: 33377985
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study.
Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Salvetti M; Trimarco B; Volpe M; Pontremoli R; Deferrari G; Rosei EA
J Hypertens; 2012 Dec; 30(12):2378-86. PubMed ID: 23137952
[TBL] [Abstract][Full Text] [Related]
6. [Chronic kidney disease (CKD) as an independent risk factor for cardiovascular disease (CVD)].
Minami J; Ishimitsu T; Sudo Y; Matsuoka H
Nihon Rinsho; 2008 Sep; 66(9):1657-63. PubMed ID: 18788391
[TBL] [Abstract][Full Text] [Related]
7. [The value of a low-protein diet and ketoanalogues of essential amino acids in the сontrol of protein carbamylation and toxic effects of urea in chronic kidney disease].
Mikhailova NA
Ter Arkh; 2021 Jun; 93(6):729-735. PubMed ID: 36286841
[TBL] [Abstract][Full Text] [Related]
8. [Inflammation, oxidative stress and kidney function in arterial hypertension].
Cerasola G; Guarneri M; Cottone S
G Ital Nefrol; 2009; 26 Suppl 46():8-13. PubMed ID: 19644813
[TBL] [Abstract][Full Text] [Related]
9. [Chronic renal disease, inflammation and atherosclerosis: new concepts about an old problem].
Dummer CD; Thomé FS; Veronese FV
Rev Assoc Med Bras (1992); 2007; 53(5):446-50. PubMed ID: 17952355
[TBL] [Abstract][Full Text] [Related]
10. [Chronic kidney disease-a cardiovascular high-risk constellation].
Speer T; Schunk SJ; Fliser D
Internist (Berl); 2020 Apr; 61(4):340-348. PubMed ID: 31578597
[TBL] [Abstract][Full Text] [Related]
11. Chronic kidney disease and cardiovascular risk.
Yerram P; Karuparthi PR; Hesemann L; Horst J; Whaley-Connell A
J Am Soc Hypertens; 2007; 1(3):178-84. PubMed ID: 20409850
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease and its relationship with chronic kidney disease.
Liu M; Li XC; Lu L; Cao Y; Sun RR; Chen S; Zhang PY
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2918-26. PubMed ID: 25339487
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review.
Cerasola G; Nardi E; Palermo A; Mulè G; Cottone S
J Nephrol; 2011; 24(1):1-10. PubMed ID: 20437402
[TBL] [Abstract][Full Text] [Related]
14. Atherosclerosis in CKD: differences from the general population.
Drüeke TB; Massy ZA
Nat Rev Nephrol; 2010 Dec; 6(12):723-35. PubMed ID: 20978469
[TBL] [Abstract][Full Text] [Related]
15. Role of Chronic Kidney Disease (CKD)-Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD.
Yamada S; Nakano T
J Atheroscler Thromb; 2023 Aug; 30(8):835-850. PubMed ID: 37258233
[TBL] [Abstract][Full Text] [Related]
16. The scope of coronary heart disease in patients with chronic kidney disease.
Hage FG; Venkataraman R; Zoghbi GJ; Perry GJ; DeMattos AM; Iskandrian AE
J Am Coll Cardiol; 2009 Jun; 53(23):2129-40. PubMed ID: 19497438
[TBL] [Abstract][Full Text] [Related]
17. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
[TBL] [Abstract][Full Text] [Related]
18. Erythropoiesis-stimulating agents, hypertension and left ventricular hypertrophy in the chronic kidney disease patient.
Schmid H; Schiffl H; Lederer SR
Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):465-70. PubMed ID: 21738032
[TBL] [Abstract][Full Text] [Related]
19. Hypertension, left ventricular hypertrophy and chronic kidney disease.
Taddei S; Nami R; Bruno RM; Quatrini I; Nuti R
Heart Fail Rev; 2011 Nov; 16(6):615-20. PubMed ID: 21116711
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
